Abstract
Uveal melanoma (UM) is the most common primary intraocular malignancy and the leading potentially fatal primary intraocular disease in adults. Melanoma antigen recognized by T-cells (MART-1) has been studied extensively as a clinically important diagnostic marker for melanoma, however, its biological function remains unclear. In the present study, the UM cell line SP6.5, which showed a high level of MART-1 expression, was subjected to small interfering RNA-mediated silencing of MART-1. Silencing of MART-1 expression increased the migration ability of SP6.5 cells and down-regulated the expression of the metastasis suppressor NM23. Our results suggest that MART-1 is a candidate target for the development of therapeutic strategies for UM and in particular for the suppression of metastasis associated with this malignancy. © 2013 by the authors; licensee MDPI, Basel, Switzerland.
Author supplied keywords
Cite
CITATION STYLE
Zhang, Y., Jia, R., Wang, J., Xu, X., Yao, Y., Ge, S., & Fan, X. (2013). Targeted silencing of MART-1 gene expression by RNA interference enhances the migration ability of uveal melanoma cells. International Journal of Molecular Sciences, 14(7), 15092–15104. https://doi.org/10.3390/ijms140715092
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.